scholarly article | Q13442814 |
P356 | DOI | 10.1507/ENDOCRJ.EJ14-0148 |
P698 | PubMed publication ID | 25328079 |
P2093 | author name string | Hisamitsu Ishihara | |
Suguru Yamaguchi | |||
Yuichiro Otsuka | |||
Asami Furukawa | |||
Minami Kosuda | |||
Mitsuhiro Nakazaki | |||
P433 | issue | 2 | |
P921 | main subject | metformin | Q19484 |
hyperglycemia | Q271993 | ||
glucagon | Q28163629 | ||
type 2 diabetes | Q3025883 | ||
preproinsulin | Q7240673 | ||
P304 | page(s) | 133-143 | |
P577 | publication date | 2014-10-19 | |
P1433 | published in | Endocrine Journal | Q5376304 |
P1476 | title | Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes | |
P478 | volume | 62 |
Q37427298 | Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin |
Q38664568 | Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin: Rationale and evidences |
Q26767260 | Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review |
Q42279452 | Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus |
Q40606871 | Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study |
Q48031376 | Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period |
Q38716033 | Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients |
Q55385577 | Neutrophils Release Metalloproteinases during Adhesion in the Presence of Insulin, but Cathepsin G in the Presence of Glucagon. |
Q38687258 | Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences |
Search more.